Result 2022

ORAL PRESENTATION

JUDGES

Dr. S D Banavali
Dr. Anant Ramaswamy
Dr. Anant Gokarn
SR. NO Submitted by Abstract Name Prize
1 Dr. Sandhya Singuluri LEARNING FROM ERRORS AND MISHAPS: AN AUDIT OF HOSPITAL MORBIDITY EVENTS FROM A MEDICAL ONCOLOGY UNIT 1st Prize
2 Dr. Syeda Hana Hussain ASSESSMENT OF LATE TOXICITIES USING PATIENT REPORTED OUTCOMES IN ORAL CANCER PATIENTS TREATED WITH SURGERY AND ADJUVANT RADIOTHERAPY 2nd Prize
3 Dr. Rajeshwari Rai ASSESSMENT OF LATE EFFECTS USING PATIENT REPORTED OUTCOMES AND FACTORS AFFECTING RETURN TO WORK IN SURVIVORS OF BREAST CANCER -

APPEAL FOR FUNDING SUPPORT TO A PLANNED BIOMEDICAL RESEARCH

JUDGES

Dr. Bharat Bhosale
Dr. Biswajit Dubashi
Dr. K Pavithran
SR. NO NAME TOPIC PRIZE
1 Dr. Sujay Srinivas A randomized, double blinded, parallel-group, phase 3 study to investigate the efficacy and tole-rability of palonosetron, dexamethasone, aprepitant plus oral cannabinoid versus palonosetron, dexamethasone, aprepitant 1st Prize
2 Dr. Pritesh Munot Two arm, triple blinded, randomized open label prospective, parallel design phase ii integrated phase iii study to evaluate the role of carica papaya leaf extract 2nd Prize
3 Dr. Abhijith Rao Cargo study - carg risk score-based chemotherapy in older patients with advanced gi cancers – phase iii trial. 3rd Prize
4 Snehal Shinde A randomized control study to assess the efficacy of curcumin and honey in cough on patients with lung cancer at a tertiary cancer center. -
5 Naphisabet Kharbithai Effects of topical application of urea and aloevera cream on handfoot syndrome in gi cancer patients receiving adjuvant 5fu containing chemotherapy -
6 Mrs. Anita D'souza Chemo care unit -
7 Dr. Sujay Srinivas An open label, prospective three-arm randomized, non-comparative study on efficacy and tolerability of orally disintegrating strip, oral tablets and intravenous administration of vitamin b12, in -
8 Sime Chacko A feasibility study: comparative evaluation of clinical breast examination vs ‘I -breast tool ’ device in screening women for early detection of breast cancer at tmh + actrec -
9 Dr. Shantanu Pendse A randomized, open label, parallel-group, phase 3 study to investigate the efficacy and tolerability of palonosetron, dexamethasone, aprepitant plus olanzapine versus palonosetron, dexamethasone and aprepitant -